Edwin B. Astwood

From Wikipedia, the free encyclopedia
Edwin Bennett Astwood
BornDecember 29, 1909
DiedFebruary 17, 1976
NationalityBermudian
AwardsCameron Prize for Therapeutics of the University of Edinburgh (1948)
Lasker Award (1954)
Scientific career
FieldsEndocrinology

Edwin Bennett Astwood (December 19, 1909 – February 17, 1976) was a Bermudian-American physiologist and endocrinologist: his research on endocrine system led to treatments for hyperthyroidism, first published in 1943 in what has subsequently been called a "landmark" paper.[1] In 1949 he showed that methimazole was superior to alternative therapies for Graves' disease and this became a standard treatment for the condition.[2]

He was elected a Fellow of the American Academy of Arts and Sciences in 1949.[3] In 1948, he was awarded the Cameron Prize for Therapeutics of the University of Edinburgh. He died of cancer on February 17, 1976, in Hamilton, Bermuda.[4]

References[edit]

  1. ^ Astwood, E. B. (1984). "Landmark article May 8, 1943: Treatment of hyperthyroidism with thiourea and thiouracil. By E.B. Astwood". JAMA: The Journal of the American Medical Association. 251 (13): 1743–1746. doi:10.1001/jama.251.13.1743. PMID 6422063.
  2. ^ Burch, Henry B.; Cooper, David S. (2018). "Antithyroid drug therapy: 70 years later". European Journal of Endocrinology. 179 (5): R261–R274. doi:10.1530/EJE-18-0678. PMID 30320502.
  3. ^ "Book of Members, 1780-2010: Chapter A" (PDF). American Academy of Arts and Sciences. Retrieved 27 April 2011.
  4. ^ "Dr. Edwin B. Astwood, 66, a leader in endocrinology". The Boston Globe. February 18, 1976 – via Newspapers.com.
  • Cooper, D. Y. Astwood, Edwin Bennett. American National Biography Online Feb. 2000.

External links[edit]